Lupus Market by Type, Application and Region - Global Market Analysis and Forecast by 2022 to 2027

 Overview:

Lupus is a chronic autoimmune disease which occurs when the immune system attacks the healthy cells and tissues of the body, thereby causing inflammation, pain, swelling, and damage throughout the body. Many people have an inherit tendency towards developing or attaining lupus, which can be triggered due to certain drugs, infections, or even sunlight. The prevalence of this condition has prompted Market Research Future (MRFR) to take notice and study the global market of the same. As of 2022, the market valuation of Lupus stood at USD 1.48 billion. However, as per the latest studies, the global lupus market size is projected to grow significantly during the forecast period with a CAGR of 11.2%.

Various factors such as the growing prevalence of lupus diseases, increasing R&D activities, and continuing medical advancements for the treatment of systemic lupus symptoms erythematosus are all identified as key factors driving the growth of the market. Also, the market involves a number of noteworthy companies that are involved in the development of new products and product launches. However, irrespective of the market drivers, constraints such as strict government regulation and rising prices of lupus drugs can severely hamper its market growth during the review period.

Competitive Landscape

The global lupus market holds a number of noteworthy players, including Merck KGaA, Cadila Healthcare, Mylan N.V., F. Hoffmann-La Roche AG, Aurinia Pharmaceuticals, Inc., GlaxoSmithKline PLC, Eli Lily and Company, Pfizer, Inc., Bristol-Myers Squibb Company, Lycera Corporation, and Sanofi.

Dec 11th, 2022, Neovacs, a pioneer in the field of active immune therapy for treating autoimmune diseases, announced the continuation of its partnership with Centurion Pharma in Lupus (SLE). This is based on the study results of the Phase IIb trial with IFNalpha Kinoid.

Market Segmentation

The Lupus Market segmentation is done on the basis of treatment, end-user, and types.

By treatment, the market includes antimalarial drugs, corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), biologics, immunosuppressants, and others.

By end-user, the market divides into diagnostic laboratories, hospitals and clinics, and others.

Lastly, by type, the market comprises cutaneous lupus erythematosus, Antibiotics lupus erythematosus, neonatal lupus, and drug-induced lupus erythematosus. The lupus erythematosus market segment is projected to hold the largest market percentage due to the increasing prevalence of such diseases and the increasing drug development over the years.

Regional Analysis

The global lupus market is geographically segmented into the following regions: Americas, Asia Pacific, Europe, and the Middle East & Africa.

The Americas is anticipated to be the most dominant regional market due to a number of factors. This includes the growing prevalence of lupus diseases, rising demand for better treatment options, favorable government initiatives, and the availability of reimbursement. In addition to these, the established healthcare infrastructure facility coupled with the accessibility to biologics are also expected to propel the market growth of this region.

The European market is believed to hold the second-largest market position following the Americas. The growth of the market herein is attributed to the expanding R&D activities and widespread prevalence of lupus diseases.

The Asia-Pacific region is expected to be the fastest-growing regional market. This can be attributed to the growing healthcare sector, the rising incidences of lupus diseases, and increasing regional expansion by prominent market players.

The Middle East & Africa region holds the least market share among all the mentioned regions.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Comments

Post a Comment

Popular posts from this blog

Sinus Dilation Devices Market Sparkling Key Players Shares, Revenue, Analysis and Forecasts to 2030

  Market Highlights Sinus is also called as chronic rhinosinusitis; it is a condition in which cavities around nasal known as (sinuses) get inflamed and swollen for weeks. The people suffering from sinus may have symptoms such as nasal block, tenderness, swelling of the face, sore throat, nausea, fatigue or irritability, and pain in jaw and teeth. The balloon sinus dilation Market is expected to witness tremendous growth owing to the rising demand for balloon sinuplasty or sinus dilation compare to conventional sinus surgeries, rising cases of bacterial infection and increasing adoption of sinus dilation devices for sinusitis. The  sinus dilation devices market size  was estimated at USD 3,326 million in 2016 and expected to reach USD 5,778 million by 2030 at a CAGR of 8.1% from 2022 to 2030. However, factors such as risks associated with the sinus surgery, low adoption of new advance devices related to sinus treatment may hinder the market growth during the forecast peri...
Read more

Breathing Disorders Treatment Market Sparkling Key Players Shares, Revenue, Analysis and Forecasts to 2030

  Breathing Disorders Treatment Market Highlights: The breathing disorders treatment market is growing pervasively over the past few years. The market is getting a boost from the rising prevalence of various diseases & disorders related to respiratory tracts, such as COPD, asthma, allergic rhinitis, pulmonary hypertension, cystic fibrosis, IPF, and others. Moreover, increasing occurrences of lung diseases alongside the increasing geriatric population accelerates the market on a global level. According to Market Research Future (MRFR), a leading research firm, the global  Breathing Disorders Treatment Market Size  may experience impressive growth by 2030. MRFR, in its recent study report, also asserts that the market would register a 7.5% CAGR during the review period (2023 – 2030). Augmenting demand for minimally invasive procedures for diagnosing & treatment supports the market growth. Recent technological advancements are fostering market growth, offering phenom...
Read more

Blood Glucose Monitoring Market Key Factor, Major Region Analysis and Forecasts Till 2030

  Blood Glucose Monitoring Market Overview: A healthy body stays healthy due to all kinds of enzymes in the body being in proper balance. Excess of an enzyme can disturb balance while deficiency of another one can have the same effect. People who are suffering from genetic ailments like diabetes are more prone to such problems. Therefore, monitoring things like glucose in the blood is necessary for such people, and this is the reason for the global blood glucose monitoring market to take shape and grow. Blood glucose monitoring helps to recognize the glucose level of blood within the specified target range. The devices facilitating this monitoring provide useful insight to manage diabetes. These insights help to track the progress of treatment goal and observe the effect of medication on blood sugar level and understand how the ailment affects glucose level in blood. Market Research Future (MRFR) has published a research report about the global blood glucose monitoring market that ...
Read more